Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial

Inclusion Criteria: * American Society of Anesthesiologists (ASA) Class 1-3 * Patients aged 18 to 65 years * Patients scheduled for primary, unilateral arthroscopic hip surgery by Dr. Kelly, Dr. Coleman, or Dr. Anil Ranawat * Planned use of neuraxial anesthesia * Body Mass Index less than 35 * Ability to follow study protocol Exclusion Criteria: * Chronic opioid use (defined as daily or almost daily use of opioids for \>3 months) * Contraindication to combined spinal-epidural anesthesia including but not limited to bleeding disorder, use of clinically relevant anticoagulant or antiplatelet medications, and anatomic abnormalities. * Contraindication to lumbar plexus block including but not limited to bleeding disorder, use of clinically relevant anticoagulant or antiplatelet medications, and anatomic abnormalities. * Infection at the injection site(s) * Allergy to any of the study medications * Contraindication to a short course of NSAIDs (renal failure, intolerance) * ASA Class 4-5 * Patient refusal * Patients younger than 18 years old and older than 65 * Patients with any known indwelling hardware of the lumbar spine. * Patients with a peripheral neuropathy of the surgical extremity * Non-English speaking patients